October 28, 2020 AstraZeneca’s response to COVID

Wednesday 28 October 2020
Back to overview

Time: 10.00 – 11.00 CET


The Swedish Chamber of Commerce have the pleasure of inviting you to an exclusive Member Business Webinar on October 28, 2020 about AstraZeneca’s reponse to COVID.

The COVID-19 pandemic is placing immediate challenges on our healthcare systems and will also have a longer lasting impact on the way we live and think about our health – and that of others – in the years to come. As ever, AstraZeneca prioritizes the needs of patients to help ensure their safety and continued access to care. In addition, AstraZeneca plays their part in helping to relieve the pressure on healthcare systems during this critical period as well as our future recovery. Ilse van Hensbeek, medical director of AstraZeneca Netherlands, will elaborate on AstraZeneca’s response to COVID, and the efforts that entails. In addition to partnering with the University of Oxford to deliver a working vaccine, AstraZeneca researches monoclonal antibody combinations as well as the use registered treatment to combat the severe complications of the virus.



10.00 Welcome

10.05 Introduction AstraZeneca by Ad Antonisse, Director Market Access & External Affairs

10.20 Progress and challenges Corona Virus by Ilse van Hensbeek, Medical Director AstraZeneca

10.35 Q&A

10.50 Conclusion

10.55 Thank you by Swedish Chamber

11.00 End of Webinar


On October 28, 2020 the Swedish Chamber of Commerce had the pleasure of hosting an exclusive Member Webinar featuring Ad Antonisse, Director Market Access & External Affairs and Ilse van Hensbeek, Medical Director of AstraZeneca Netherlands about AstraZeneca’s response to COVID. This webinar was part of the Swedish Chamber’s series “for members by members” and we were very pleased to welcome around 30 members including H.E. Ambassador of Sweden Mrs. Annika Markovic. We would like to thank Ad and Ilse for introducing us to the world of AstraZeneca and their impressive work prioritizing the needs of patients, helping and ensuring their safety and access to care, helping to relieve the pressure on healthcare systems during this critical period as well as our future recovery and last but not least in finding and delivering a working vaccine to fight the corona virus.



Participation Fee

Participation Fee Swedish Chamber Members: Free of Charge

Participation Fee YP Members of the Swedish Chamber Free of Charge

Non-Members Euro 12,50

Registration details

Register digitally or by sending an email to events@swedishchamber.nl.

Upon registration you will receive a confirmation and a link to join the meeting.